Repatha and Injection site swelling - a phase IV clinical study of FDA data

Summary:

We study 131,642 people who have side effects when taking Repatha. Injection site swelling is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Plavix and have Hyperlipidaemia.

The phase IV clinical study analyzes which people take Repatha and have Injection site swelling. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 23, 2023

131,642 people reported to have side effects when taking Repatha.
Among them, 2,031 people (1.54%) have Injection site swelling.

What is Repatha?

Repatha has active ingredients of evolocumab. It is used in high blood cholesterol. Currently, eHealthMe is studying from 131,958 Repatha users.

What is Injection site swelling?

Injection site swelling is found to be associated with 1,674 drugs and 1,077 conditions by eHealthMe. Currently, we are studying 64,994 people who have Injection site swelling.

Number of Repatha and Injection site swelling reports submitted per year:

Could Repatha cause Injection site swelling?

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and have Injection site swelling?

Check whether Injection site swelling is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Repatha side effects by duration, gender and age:

Repatha side effects (131,958 reports)

Injection site swelling treatments and more:

Injection site swelling (64,994 reports)

Common drugs associated with Injection site swelling:

All the drugs that are associated with Injection site swelling:

Injection site swelling (1,674 drugs)

Common conditions associated with Injection site swelling:

Rheumatoid arthritis: 16,901 reports
Psoriasis: 5,693 reports
Crohn's disease: 2,634 reports
Multiple sclerosis: 2,528 reports

All the conditions that are associated with Injection site swelling:

Injection site swelling (1,077 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on evolocumab (the active ingredients of Repatha) and Repatha (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.